Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Becton Dickinson and Company

BDX
233,69
6,91 (3,05%)
31 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/5/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:26EDGAR2Form 144 - Report of proposed sale of securities
15/5/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202412:45PRNUSWomen in U.S. Can Now Collect Their Own Sample for Cervical..
13/5/202422:23EDGAR2Form 144 - Report of proposed sale of securities
10/5/202413:15EDGAR2Form SD - Specialized disclosure report
06/5/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/5/202412:30PRNUSBD Reports Second Quarter Fiscal 2024 Financial Results
30/4/202422:15PRNUSBD Board Declares Dividend
29/4/202422:15PRNUSBD to Present at Bank of America Securities Health Care..
09/4/202416:15PRNUSBD Named a Best Employer for Excellence in Employee..
05/4/202412:45PRNUSBD Increases Access to Cutting-Edge Image-Enabled, Spectral..
04/4/202422:15PRNUSBD to Announce Financial Results for its Second Quarter of..
27/3/202411:50PRNUSNew Survey Reveals Patients Receive Too Many Needlesticks
26/3/202414:31PRNUSBD Named Among Fortune's Most Innovative Companies
21/3/202411:50PRNUSBD Increases Domestic Production to Support U.S. Health Care..
18/3/202411:50PRNUSBD and Health Care Consortium in Denmark Find Success in..
14/3/202418:00PRNUSZeus Names New Chief Executive Officer
13/3/202411:50PRNUSNew Study Highlights Benefits of Medication Management..
05/3/202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:50PRNUSBD Initiates International Study to Expand Treatment Options..
27/2/202412:54EDGAR2Form 8-K - Current report
27/2/202412:50PRNUSDave Hickey Announces Intent to Retire from BD
21/2/202412:45PRNUSBD Partners with Camtech Health to Increase Access to..
16/2/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202422:15PRNUSBD to Present at Investor Healthcare Conferences
12/2/202422:43PRNUSBD to Present Next Installment of BD Innovates Series:..
09/2/202422:39EDGAR2Form CERT - Certification by an exchange approving..
09/2/202422:23EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
08/2/202422:19EDGAR2Form 8-K - Current report
07/2/202423:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
07/2/202423:16EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
07/2/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:31EDGAR2Form 8-K - Current report
05/2/202423:26EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
05/2/202418:52EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
05/2/202414:47EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
05/2/202412:14EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
01/2/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202412:33EDGAR2Form 8-K - Current report
01/2/202412:30PRNUSBD Reports First Quarter Fiscal 2024 Financial Results
30/1/202412:45PRNUSBD, Techcyte Announce Strategic Collaboration to Offer..
26/1/202422:34EDGAR2Form 8-K - Current report
25/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 227,21 Min: 226,32 Max: 232,21
Chiusura: 226,78

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network